{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T23:38:59Z","timestamp":1719272339522},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0130580","type":"journal-article","created":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T17:40:13Z","timestamp":1436290813000},"page":"e0130580","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique"],"prefix":"10.1371","volume":"10","author":[{"given":"Dulce Celina Adolfo","family":"Bila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00eddia Teodoro","family":"Boullosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo Salvador","family":"Vubil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9dio Jonas","family":"Mabunda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celina Monteiro","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalia","family":"Ismael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilesh Vinodrai","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amilcar","family":"Tanuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,7,7]]},"reference":[{"key":"ref1","unstructured":"National Institute of Health NI of S (Mozambique) and C for DC (US). National Survey on Prevalence, Behavioral Risks and Information about HIV and AIDS (2009 INSIDA). 2009."},{"key":"ref2","unstructured":"Comit\u00e9 Nacional de Assist\u00eancia M\u00e9dica e Colaboradores. Guia de Tratamento Antiretroviral e Infec\u00e7\u00f5es Oportunistas no Adulto, Adolescente e Gr\u00e1vida."},{"key":"ref3","article-title":"Antiretroviral therapy for HIV infection in adults and adolescents","year":"2010","journal-title":"Recommendations for a public health approach"},{"key":"ref4","unstructured":"Mozambique Ministry of Health. Dados TARV Nacionais ate Dezembro 2012 Final. In: 2013 [Internet]. 2013. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.misau.gov.mz\/index.php\/hiv-sida\/cat_view\/82-hivsida\/89-informacao-estrategica-relatorios\/90-relatorios-tarv\" xlink:type=\"simple\">http:\/\/www.misau.gov.mz\/index.php\/hiv-sida\/cat_view\/82-hivsida\/89-informacao-estrategica-relatorios\/90-relatorios-tarv<\/ext-link>"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(06)69158-7","article-title":"The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings","volume":"368","author":"CF Gilks","year":"2006","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/01.inf.0000091282.70253.5f","article-title":"Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children","volume":"22","author":"JM S\u00e1nchez","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":"Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries","volume":"367","author":"P Braitstein","year":"2006","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-3156.2009.02259.x","article-title":"Reduced morbidity and mortality in the first year after initiating highly active anti-retroviral therapy (HAART) among ugandan adults","volume":"14","author":"G Miiro","year":"2009","journal-title":"Trop Med Int Heal"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"FJ Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"10324","DOI":"10.1016\/S0021-9258(18)82205-0","article-title":"Error-prone polymerization by HIV-1 reverse transcriptase. Contribution of template-primer misalignment, miscoding, and termination probability to mutational hot spots","volume":"268","author":"K Bebenek","year":"1993","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/JVI.68.3.1660-1666.1994","article-title":"Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy","volume":"68","author":"DD Richman","year":"1994","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/108729104323076007","article-title":"Preventing and managing antiretroviral drug resistance","volume":"18","author":"DR Kuritzkes","year":"2004","journal-title":"AIDS Patient Care STDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200301030-00001","article-title":"A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors","volume":"17","author":"B Brenner","year":"2003","journal-title":"AIDS"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/QAI.0b013e3181bc478b","article-title":"Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South Africa","volume":"53","author":"CL Wallis","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/135965350901400414","article-title":"HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme","volume":"14","author":"C Orrell","year":"2009","journal-title":"Antivir Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1086\/587109","article-title":"Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa","volume":"46","author":"VC Marconi","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"F9","DOI":"10.1097\/01.aids.0000232228.88511.0b","article-title":"HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture","volume":"20","author":"BG Brenner","year":"2006","journal-title":"AIDS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1097\/QAD.0b013e328356886d","article-title":"High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen","volume":"26","author":"H Sunpath","year":"2012","journal-title":"AIDS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/jmv.21567","article-title":"Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel","volume":"81","author":"D Turner","year":"2009","journal-title":"J Med Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00705-008-0215-6","article-title":"Genotypic and phenotypic characterization of human immunodeficiency virus type 1 isolates circulating in pregnant women from Mozambique","volume":"153","author":"CM Abreu","year":"2008","journal-title":"Arch Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00002030-200301030-00004","article-title":"A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil","volume":"17","author":"MA Soares","year":"2003","journal-title":"AIDS"},{"key":"ref22","unstructured":"Drug Resistance Analysis. In: Stanford University [Internet]. 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/sierra2.stanford.edu\/sierra\/servlet\/JSierra?action=sequenceInput\" xlink:type=\"simple\">http:\/\/sierra2.stanford.edu\/sierra\/servlet\/JSierra?action=sequenceInput<\/ext-link>"},{"key":"ref23","unstructured":"Mega Software [Internet]. 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.megasoftware.net\/\" xlink:type=\"simple\">http:\/\/www.megasoftware.net\/<\/ext-link>"},{"key":"ref24","unstructured":"HIV Recombination Analysis. In: University of Gottingen [Internet]. 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/jphmm.gobics.de\/submission_hiv\" xlink:type=\"simple\">http:\/\/jphmm.gobics.de\/submission_hiv<\/ext-link>"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(06)68580-2","article-title":"Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment","volume":"367","author":"L Ferradini","year":"2006","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/135965350801302S07","article-title":"World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites","author":"MR Jordan","year":"2008","journal-title":"Antiviral Therapy"},{"key":"ref27","article-title":"Four-year treatment outcomes of adult patients enrolled in Mozambique\u2019s rapidly expanding antiretroviral therapy program","volume":"6","author":"AF Auld","year":"2011","journal-title":"PLoS One"},{"key":"ref28","article-title":"Incomplete immune recovery in HIV infection: Mechanisms, relevance for clinical care, and possible solutions","author":"JC Gaardbo","year":"2012","journal-title":"Clinical and Developmental Immunology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/1874613601206010016","article-title":"Immune Reconstitution During the First Year of Antiretroviral Therapy of HIV-1-Infected Adults in Rural Burkina Faso","author":"F Tiba","year":"2012","journal-title":"The Open AIDS Journal"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-2478(98)00159-X","article-title":"Restoration of the immune system with anti-retroviral therapy","author":"B Autran","year":"1999","journal-title":"Immunology Letters"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/135965350100600303","article-title":"Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy","volume":"6","author":"M Mouroux","year":"2001","journal-title":"Antivir Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/QAD.0b013e32832ac34e","article-title":"The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy","volume":"23","author":"MC Hosseinipour","year":"2009","journal-title":"AIDS"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1089\/aid.2006.0310","article-title":"Baseline genotype as a predictor of virological failure to emtricitabine or stavudine in combination with didanosine and efavirenz","volume":"23","author":"K Borroto-Esoda","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"S-Y Rhee","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"DE Bennett","year":"2009","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1093\/jac\/dkt200","article-title":"Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors","volume":"68","author":"S Fourati","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"ref37","first-page":"67","article-title":"HIV-1 drug resistance mutations: An updated framework for the second decade of HAART","author":"RW Shafer","year":"2008","journal-title":"AIDS Reviews"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2011.03.007","article-title":"Reverse transcriptase mutation K65N confers a decreased replication capacity to HIV-1 in comparison to K65R due to a decreased RT processivity","volume":"414","author":"H Chunduri","year":"2011","journal-title":"Virology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/135965350801302S13","article-title":"Consensus drug resistance mutations for epidemiological surveillance: Basic principles and potential controversies","author":"RW Shafer","year":"2008","journal-title":"Antiviral Therapy"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0130580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T19:47:13Z","timestamp":1652816833000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0130580"}},"subtitle":[],"editor":[{"given":"Nicolas","family":"Sluis-Cremer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,7]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0130580","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,7]]}}}